GMVRX
Price
$18.96
Change
-$0.18 (-0.94%)
Updated
Jul 13 closing price
Net Assets
152.73M
VMCPX
Price
$436.25
Change
-$0.56 (-0.13%)
Updated
Jul 13 closing price
Net Assets
223.97B
Interact to see
Advertisement

GMVRX vs VMCPX

GMVRX vs VMCPX Comparison Chart in %
View a ticker or compare two or three
VS
GMVRX vs. VMCPX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GMVRX is a Hold and VMCPX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VMCPX has more cash in the bank: 224B vs. GMVRX (153M). VMCPX pays higher dividends than GMVRX: VMCPX (1.34) vs GMVRX (0.00). GMVRX was incepted earlier than VMCPX: GMVRX (12 years) vs VMCPX (16 years). GMVRX (1.70) is less costly to investors than VMCPX (0.02). GMVRX is a more actively managed with annual turnover of: 100.00 vs. VMCPX (16.00). GMVRX has a lower initial minimum investment than VMCPX: GMVRX (0) vs VMCPX (100000000). GMVRX annual gain was more profitable for investors over the last year : 17.42 vs. VMCPX (14.86). VMCPX return over 5 years is better than : 38.76 vs. GMVRX (17.52).
GMVRXVMCPXGMVRX / VMCPX
Total Expense Ratio1.420.027,100%
Annual Report Gross Expense Ratio1.700.028,500%
Fund Existence12 years16 years-
Gain YTD17.93011.656154%
Front LoadN/AN/A-
Min. Initial Investment0100000000-
Min. Initial Investment IRAN/AN/A-
Net Assets153M224B0%
Annual Yield % from dividends0.001.34-
Returns for 1 year17.4214.86117%
Returns for 3 years32.7444.8273%
Returns for 5 years17.5238.7645%
Returns for 10 years79.38158.8150%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NRACX61.12N/A
N/A
Neuberger Quality Equity C
RMDAX5.00N/A
N/A
Virtus Silvant Mid-Cap Growth A
MUEVX44.14N/A
N/A
MFS Blended Research Core Equity R6
LCFLX16.05N/A
N/A
Lord Abbett Focused Large Cap Value C
RNPBX68.69-0.93
-1.34%
American Funds New Perspective R-2